Conditional EU Nod for Weekly Pill in Pediatric Glioma

Published Date: 02 Mar 2026

Current treatment options include surgery and chemotherapy, but chemotherapy’s benefits are often modest and can cause substantial side effects.

Read Full News

Latest News

SBRT May Beat Brachytherapy in Prostate Cancer

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?

Researchers examined whether CDK4/6 inhibitors lead to better overall survival when used as first- or second-line treatment.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

Patients with breast cancer living in states with expanded Medicaid eligibility, have seen survival gains, raising more concerns about the impact of recent changes to the program.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.

Cancer and HIV Vaccines Enter the Therapeutic Era

Therapeutic vaccines are advancing in oncology and HIV, with the aim of retraining immune responses to target tumors and persistent viral reservoirs with precision.

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

Ten-year survival data support salvage focal therapy as an option for patients with localized recurrence after prostate cancer radiotherapy.

Todays Updates

New Book Spotlights Medicine’s Emotional Side

A new anthology, Where It Hurts: Dispatches from the Emotional Frontlines of Medicine, explores how doctors process the day-to-day challenges of their careers.

Will a Smart Toilet Turn the Home Into a Diagnostic Center?

Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain.

Bayer Sues Johnson & Johnson Over Claim That Prostate Cancer Drug Cuts Risk Of Death

Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar drug cuts the ⁠risk of death from prostate...

NICE Backs Paperclip-Sized Sensor for Heart Failure Care

The CardioMEMS HF System enables daily home monitoring and has been shown to reduce hospital admissions in high-risk patients with chronic heart failure.

Dual Biologics May End Daily Pills Post-Kidney Transplant

A novel dual biologic regimen combining dazodalibep and belatacept is well tolerated and could enable more than half the kidney transplant recipients to avoid broader metabolic pathway inhibitors.

Which Imaging Method Best Detects At-Risk MASH?

Noninvasive imaging tests may help identify at-risk metabolic dysfunction-associated steatohepatitis, with a FibroScan-based scoring system performing best among commonly used methods.

FMT May Clear Drug Resistant Pseudomonas in Blood Cancer

Faecal microbiota transplantation appears to be effective in decolonising carbapenem-resistant Pseudomonas and is safe in patients with hematologic malignancies, a retrospective analysis shows.

Todays Updates

New Book Spotlights Medicine’s Emotional Side

A new anthology, Where It Hurts: Dispatches from the Emotional Frontlines of Medicine, explores how doctors process the day-to-day challenges of their careers.

Will a Smart Toilet Turn the Home Into a Diagnostic Center?

Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain.

Bayer Sues Johnson & Johnson Over Claim That Prostate Cancer Drug Cuts Risk Of Death

Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar drug cuts the ⁠risk of death from prostate...

NICE Backs Paperclip-Sized Sensor for Heart Failure Care

The CardioMEMS HF System enables daily home monitoring and has been shown to reduce hospital admissions in high-risk patients with chronic heart failure.

Dual Biologics May End Daily Pills Post-Kidney Transplant

A novel dual biologic regimen combining dazodalibep and belatacept is well tolerated and could enable more than half the kidney transplant recipients to avoid broader metabolic pathway inhibitors.

Which Imaging Method Best Detects At-Risk MASH?

Noninvasive imaging tests may help identify at-risk metabolic dysfunction-associated steatohepatitis, with a FibroScan-based scoring system performing best among commonly used methods.

FMT May Clear Drug Resistant Pseudomonas in Blood Cancer

Faecal microbiota transplantation appears to be effective in decolonising carbapenem-resistant Pseudomonas and is safe in patients with hematologic malignancies, a retrospective analysis shows.

Latest News

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

Researchers examined whether CDK4/6 inhibitors lead to better overall survival when used as first- or second-line treatment.

Patients with breast cancer living in states with expanded Medicaid eligibility, have seen survival gains, raising more concerns about the impact of recent changes to the program.

The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.

Therapeutic vaccines are advancing in oncology and HIV, with the aim of retraining immune responses to target tumors and persistent viral reservoirs with precision.

Ten-year survival data support salvage focal therapy as an option for patients with localized recurrence after prostate cancer radiotherapy.

News All Time

Bromelain and Antibiotics Aid Crans-Montana Burn Care

Experience from Crans-Montana shows how rapid eschar removal and targeted antimicrobials can reduce the surgical burden and complications in patients with severe burn injuries.

Expert Algorithm Offered for Treating Lichen Planopilaris

Optimized treatment of lichen planopilaris should be individualized in the context of presenting symptoms and features, according to a newly tweaked algorithm.

US Plastic Surgeons Group Advises Delaying Gender Surgery Until Age 19 Due to Insufficient Evidence

The American Society of Plastic Surgeons issued a statement on Tuesday recommending surgeons delay gender-related breast or chest, ‌genital and facial surgery until a...

Skin Penetration Enhancers

Current research considers multiple factors in divining the optimal approaches and ingredients for enhancing the penetration of drugs, cosmetics, and cosmeceuticals into the skin.

New Data on Antidepressants and Bleeding Risk in TBI

A population-based study explores the relationship between preinjury antidepressant use and short-term outcomes after traumatic brain injury.

Instagram Chief Defends Youth Mental Health Decisions

The top executive at Meta Platforms' Instagram defended the social media platform's choices around features that some company insiders called harmful to young users, at a...

Negative Pressure Wound Therapy in Limb Preservation

Dr David Armstrong explains how negative pressure wound therapy can be transformative in limb preservation, but only when it is used appropriately.

S2 Episode 5: HER2 Low Testing in the ADC Era

Drs Kathy Miller and Sunil Badve discuss how HER2 testing has evolved over time as the need for that clinical testing has shifted, including assay limits, biology, and clinical impact.

U.S. Surgeon General Nominee Means Says She Backs Vaccines, With Parental Conversations

Casey Means, President ⁠Donald Trump's nominee for U.S. ⁠surgeon general and an ally of ⁠Health Secretary ‌Robert F. Kennedy Jr., said before the Senate's Health, Education,...

FDA Vaccine Advisers to Meet in March on Flu Strain Selection

The U.S. Food and Drug Administration said on Wednesday ⁠its advisory committee is set to meet on March 12 to ⁠discuss and make recommendations on the strain composition of...

South Carolina Measles Cases Easing Earlier Than Expected, Health Official Says

South Carolina has reported a drop in measles cases over the past ⁠two weeks, an encouraging sign that the outbreak may be easing earlier than anticipated, a state health...

Gilead's Experimental HIV Treatment Shows Low Discontinuation Rates in Studies

Gilead Sciences on Wednesday said its experimental single-tablet HIV treatment was ⁠generally well tolerated with low discontinuation rates, positioning the single-tablet...

CROI 2026

Read clinically focused news coverage of key developments from CROI 2026.

Managing Chronic Hepatitis B: New Guideline Expands Options

Joint AASLD/IDSA practice recommendations reflect new data on prevention, treatment, and surveillance of chronic hepatitis B, emphasizing collaborative decision-making.

Treating Cancer by Molecular Footprint, Not Organ

Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.

Risk-Reducing Mastectomy in BRCA1/2: Does It Save Lives?

Two recent studies aim to clarify whether risk-reducing bilateral mastectomy among BRCA1/2 carriers can improve survival, but the findings underscore the limits of the current evidence.

Recommended News For You

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

Trump slashed US cancer research by 31 percent: Senate report

With the use of a novel sequencing technique, pediatric bone marrow transplant mortality can be predicted by analyzing lung microbiomes.

Financial hardship common in patients with cancer

A new theranostic drug targets different cancer types.

Potential new therapy for childhood brain cancer could heal treatment-resistant tumors

Recommended Articles For You

Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025 

Case Study: Artificial Intelligence in Early Cancer Detection 

Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma 

Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

2.

ALK-positive lung cancer trial results show unprecedented progression-free survival.

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

5.

Medical Journal March 28, 2023

1.

KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer

2.

Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research

3.

Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis

4.

Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management

5.

The Role of Calcium Corrections in Accurate Blood Test Results 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Updates on Standard V/S High Risk Myeloma Treatment

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

3.

Oropharyngeal Cancer in Relation to HPV Status

4.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot